NanoString Technologies Inc (NSTG) - Product Pipeline Analysis

 Published On: May, 2017 |    No of Pages: 39 |  Published By: GlobalData | Format: PDF
Request Free Sample

Summary

NanoString Technologies Inc (NanoString) is a provider of life science products and tools for translational research and molecular diagnostics. The company's products portfolio includes sprint profiler, Dx analysis system with flex, MAX analysis system, protein assays, solid tumor assays, gene fusion panels, RNA panels, DNA assays, immunology panel, gene expression codesets, pancancer immune profiling and pathways among others. NanoString's nCounter analysis system provides cost-effective method to profile hundreds of miRNA, miRGE or DNA molecules simultaneously employing digital molecular barcoding technology. The company sells its products through direct sales force and distributors in the US, Europe, the Middle East and Asia-Pacific. NanoString is headquartered in Seattle, Washington, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company NanoString Technologies Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
NanoString Technologies Inc Company Overview 5
NanoString Technologies Inc Company Snapshot 5
NanoString Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 5
NanoString Technologies Inc - Pipeline Analysis Overview 8
NanoString Technologies Inc - Key Facts 8
NanoString Technologies Inc - Major Products and Services 9
NanoString Technologies Inc Pipeline Products by Development Stage 10
NanoString Technologies Inc Pipeline Products Overview 12
Advanced Gene Expression Assay 12
Advanced Gene Expression Assay Product Overview 12
Companion Diagnostic Assay - Diffuse Large B-Cell Lymphoma (DLBCL) 13
Companion Diagnostic Assay - Diffuse Large B-Cell Lymphoma (DLBCL) Product Overview 13
Companion Diagnostic Test - Enzalutamide 14
Companion Diagnostic Test - Enzalutamide Product Overview 14
Digital Immunohistochemistry Device 15
Digital Immunohistochemistry Device Product Overview 15
Immune-Related Gene Expression Assay 16
Immune-Related Gene Expression Assay Product Overview 16
In Vitro Diagnostic Assay - HCC Gene Signature 17
In Vitro Diagnostic Assay - HCC Gene Signature Product Overview 17
Multi-Omic Assay 18
Multi-Omic Assay Product Overview 18
nCounter Vantage DNA Solid Tumor Panel 19
nCounter Vantage DNA Solid Tumor Panel Product Overview 19
nCounter Vantage RNA:Protein Solid Tumor Pathways Panel 20
nCounter Vantage RNA:Protein Solid Tumor Pathways Panel Product Overview 20
NanoString Technologies Inc - Key Competitors 21
NanoString Technologies Inc - Key Employees 22
NanoString Technologies Inc - Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
NanoString Technologies Inc, Recent Developments 24
May 04, 2017: NanoString Technologies Releases Operating Results for First Quarter of 2017 24
Apr 03, 2017: Digital Spatial Profiling Technology Enables Quantitative Protein Profiling in FFPE Tissue Providing Detailed Molecular Characterization of Immune Response to Tumors 25
Mar 23, 2017: NanoString Launches New PlexSet Technology as an Alternative to qPCR for Multiplexed High-Throughput Gene Expression Studies 26
Mar 01, 2017: NanoString Technologies Releases Fourth Quarter and Full Year 2016 Operating Results and Provides 2017 Outlook 27
Jan 31, 2017: Humana Issues Positive Coverage Decision for NanoString's Prosigna Breast Cancer Assay 28
Jan 10, 2017: NanoString Technologies Provides Preliminary Operational and Financial Results for 2016 29
Jan 10, 2017: Blue Cross Blue Shield Association Evidence Street Issues Positive Assessment for NanoString's Prosigna Breast Cancer Assay 29
Dec 12, 2016: Prosigna Breast Cancer Assay Outperforms All Other Commercial Assays Tested in Updated Analysis of TransATAC Study Presented at the 39th Annual CTRC-AACR San Antonio Breast Cancer Symposium 30
Dec 05, 2016: NanoString Technologies Highlights Presentation of Multiple Prosigna/PAM50 and Immuno-Oncology Studies at the 39th Annual CTRC-AACR San Antonio Breast Cancer Symposium 32
Nov 18, 2016: NanoString Enhances Solid Tumor Profiling with 3D Biology Capabilities for Formalin-Fixed, Paraffin-Embedded (FFPE) Tissue Samples 35
Appendix 36
Methodology 36
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
NanoString Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 5
NanoString Technologies Inc Pipeline Products by Equipment Type 6
NanoString Technologies Inc Pipeline Products by Indication 7
NanoString Technologies Inc, Key Facts 8
NanoString Technologies Inc, Major Products and Services 9
NanoString Technologies Inc Number of Pipeline Products by Development Stage 10
NanoString Technologies Inc Pipeline Products Summary by Development Stage 11
Advanced Gene Expression Assay - Product Status 12
Advanced Gene Expression Assay - Product Description 12
Companion Diagnostic Assay - Diffuse Large B-Cell Lymphoma (DLBCL) - Product Status 13
Companion Diagnostic Assay - Diffuse Large B-Cell Lymphoma (DLBCL) - Product Description 13
Companion Diagnostic Test - Enzalutamide - Product Status 14
Companion Diagnostic Test - Enzalutamide - Product Description 14
Digital Immunohistochemistry Device - Product Status 15
Digital Immunohistochemistry Device - Product Description 15
Immune-Related Gene Expression Assay - Product Status 16
Immune-Related Gene Expression Assay - Product Description 16
In Vitro Diagnostic Assay - HCC Gene Signature - Product Status 17
In Vitro Diagnostic Assay - HCC Gene Signature - Product Description 17
Multi-Omic Assay - Product Status 18
Multi-Omic Assay - Product Description 18
nCounter Vantage DNA Solid Tumor Panel - Product Status 19
nCounter Vantage DNA Solid Tumor Panel - Product Description 19
nCounter Vantage RNA:Protein Solid Tumor Pathways Panel - Product Status 20
nCounter Vantage RNA:Protein Solid Tumor Pathways Panel - Product Description 20
NanoString Technologies Inc, Key Employees 22
Glossary 37


List of Figures
NanoString Technologies Inc Pipeline Products by Equipment Type 6
NanoString Technologies Inc Pipeline Products by Development Stage 10


If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.